Navigation Links
Genaera Corporation Announces 2007 Financial Results
Date:3/31/2008

(and it is not obligated) to publicly update, revise or correct these forward-looking statements or the risk factors that may relate thereto.

GENAERA CORPORATION

STATEMENTS OF OPERATIONS

(In thousands, except per share data)

Year Ended Quarter Ended

December 31, December 31,

2007 2006 2007 2006

Revenues $ 2,737 $ 892 $ 76 $ 528

Costs and expenses:

Research and development 13,097 17,669 3,640 3,057

General and administrative 6,792 5,996 2,534 1,505

19,889 23,665 6,174 4,562

Loss from operations (17,152) (22,773) (6,098) (4,034)

Interest income 1,278 1,542 268 422

Loss on sale of fixed assets -- (3) -- (3)

Loss before income taxes (15,874) (21,234) (5,830) (3,615)

Income tax benefit 147 -- -- --

Net loss $(15,727) $(21,234) $(5,830) $(3,615)

Net loss per share -

basic and diluted $ (0.90) $ (1.46) $ (0.33) $ (0.21)

Weighted average shares

outstanding - basic and 17,452 14,513 17,461 17,435

diluted

CONDENSED BALANCE SHEETS

(In thousands)

December 31, 2007 December 31, 2006

Cash, cash equivalents and

short-term investments $20,900 $33,806

Prepaid expenses and other

current assets 356
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Genaera Elects New Board Member and Announces Executive Appointments
2. Genaera to Present at Biotech 2007 and BIO InvestorForum
3. Genaera Corporation Announces Third Quarter Financial Results
4. Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
5. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
6. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
7. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
8. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
9. BioElectronics Corporation Announces Singapore and Malaysia Sales
10. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
11. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., INCLINEVILLAGE,Nev.,Nov.23/PRNewswire-FirstCa...ouncedthatNASDAQhasestablishedNovember27,2009asthe...tockholdersresultingfromthesecuritizationtransacti...nDecember15,2009toallstockholdersofrecordonthereco...rshareamountofthedividendat$1.67pershareofcommonst...
(Date:11/23/2009)..., LANSING,Mich.,Nov.23/PRNewswire-FirstCall/--N...ichardT.Crowder,Ph.D.,waselectedtoNeogen,sBoardofD...lders. ,, Crowderhasmorethan40yearsofexperience...lyservesasanadjunctprofessorofagriculturaleconomic...007,heservedasUnitedStateschiefagriculturenegotiat...
(Date:11/23/2009)..., SEATTLE,Nov.23/PRNewswire/--ImmuneDesignC or ...edIDCasExecutiveChairman.Dr.Carterhasasuccessfultr...sthef or merChiefExecutiveOfficeratZymoGenetics,in...,Copenhagen,Denmark. ,, (Photo: http://www.news...tevenReed,IDC,sfounderandChiefExecutiveOfficercomm...
(Date:11/23/2009)..., MOUNTAINVIEW,Calif.,Nov.23/PRNewswire/--Frost...ealthcarecompaniesfordemonstratingleadershipandinn...althcareInnovationAwardsBanquetheldinSanAntonio,Te...rnh/20081117/FSLOGO ) ,, TheHealthcareInnovatio...contributiontothedeliveryandmanagementofhealthcare...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Richard T. Crowder Joins Neogen's Board of Directors 2Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3
...ring of outstanding convertible debentures of Vict...t , , QUEBEC, April 30 /PRNewswire-FirstCall/ - V...d Otto Bock HealthCare GmbH ("Otto Bock") announce...ership agreement to establish a joint venture to d...developed by Victhom,s Neurobionix division. , The...
... April 30 /PRNewswire-Asia-FirstCall/ -- China-Bio... Company"), a leading Chinese firm,specializing in... and,distribution of probiotics products ( http://... Company,s management will present at the upcoming...lations in New York on May 18,2009. , The date...
...RNewswire-FirstCall/ - Oncolytics Biotech Inc. (TS...2009 Annual and Special Meeting of the Shareholder.... (MT) at the Telus World of Science, 701-11 Stree... the meeting, Dr. Brad Thompson, President and CEO...veloping REOLYSIN(R) as a potential cancer therape...
Other Biology Technology:Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 2Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 3Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 4Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 5China-Biotics, Inc. to Present at CCG Investor Relations' China Rising Conference 2China-Biotics, Inc. to Present at CCG Investor Relations' China Rising Conference 3Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting 2
(Date:11/23/2009)... biomedical engineer and cardiologist Tzung "John"...ans distinguish cardiac emergencies requiring imme...h drugs and lifestyle change. , Angiograms, imag...eding the heart, offer an inside view of the inter...n revealing deposits of a dangerous fatty substanc...
(Date:11/23/2009)...edical Sciences (NIGMS), part of the National Inst... for grants in scientific areas it identified as "...ant program to stimulate biomedical research and t...covery and Reinvestment Act (Recovery Act). , "T...significant impact on a field of biomedical scienc...
(Date:11/23/2009)...tor of the Interuniversity Professorship in Law an...niversity of the Basque Country. The Professorship...experts such as researchers in the fields of molec...ics. , The Interuniversity Professorship in Law ...o and the Basque Country was created in 1993. The ...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research and legislation should go hand in hand, as much as possible 2For Chest Pain in the ER CT Angiography May Be Best 61756 1Artemisinin Resistance Threatens Efforts to Control Malaria 61752 1Artemisinin Resistance Threatens Efforts to Control Malaria 61752 2Artemisinin Resistance Threatens Efforts to Control Malaria 61752 3Artemisinin Resistance Threatens Efforts to Control Malaria 61752 4U S Government Acts to Ameliorate Guatemala Malnutrition Crisis 61748 1U S Government Acts to Ameliorate Guatemala Malnutrition Crisis 61748 2
...nal water sports could all be adversely affected i...coming years prove true, according to research pub...ls . , Scientists from Biotechnology and Biologic...Wyke Research have found for the first time that t...on the amount of phosphorus lost from the soil int...
...Envisat and the Italian Space Agency,s COSMO-SkyMe... Earth during and after the 6.3 earthquake that sh... on 6 April 2009. , Scientists from Italy,s Istit...ente (IREA-CNR) and the Istituto Nazionale di Geof... Aperture Radar (SAR) data from these satellites t...
...director of the Frances and Joseph Weinberg Unit f...ciences at Thomas Jefferson University was recentl...dation grant to identify why drug therapies that s...S) mouse models have proven unsuccessful in human ...eam will closely examine critical aspects of drug ...
Other Biology News:Changing climate will lead to devastating loss of phosphorus from soil 2Satellites show how Earth moved during Italy quake 2Jefferson researcher awarded Landenberger Foundation grant for ALS research 2
...ue Arrays are intended for laboratory research use...al buffered formalin and embedded in paraffin. Ti... certified pathologists. Tissue cores were remove...new recipient paraffin block, in an array pattern,...
...ue Arrays are intended for laboratory research use...al buffered formalin and embedded in paraffin. Ti... certified pathologists. Tissue cores were remove...new recipient paraffin block, in an array pattern,...
...n rat tissue extracts (liver, kidney, spleen, and ... was also tested with microsomal fractions prepare...simple and reliable method for measuring NDPase ac...ction of the inorganic phosphate released from NDP...
CNS Side Effect Profile (CNS SEP) from Novascreen-a Caliper Life Sciences Company
Biology Products: